The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.
about
The Renin-Angiotensin-aldosterone system in vascular inflammation and remodelingA unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptorHuman physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.Divergent mechanism regulating fluid intake and metabolism by the brain renin-angiotensin systemAssociation of angiotensin-converting enzyme inhibitor therapy and comorbidity in diabetes: results from the Vermont diabetes information systemQuinaprilat: a review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application.Vascular wall ACE is not required for atherogenesis in ApoE(-/-) mice.Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodelingAngiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit modelCardiovascular agents affect the tone of pulmonary arteries and veins in precision-cut lung slices.Perindopril: the evidence of its therapeutic impact in hypertension.ACE inhibition and atherogenesis.Amlodipine versus Angiotensin-receptor blockers for nonhypertension indications.Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease--pathophysiological considerations.New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibitionNew perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.Rat Ace allele variation determines susceptibility to AngII-induced renal damageSerum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis PatientsPrevention of salt induced hypertension and fibrosis by angiotensin converting enzyme inhibitors in Dahl S rats.Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.The hematopoietic system: a new niche for the renin-angiotensin system.A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone systemUse of the ACE inhibitor zofenopril in the treatment of ischemic heart disease.Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.The Renin Report.Angiotensin-converting enzyme inhibitors and coronary heart disease prevention.New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis.High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells.A role of the (pro)renin receptor in neuronal cell differentiation.Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function.Angiotensin-converting enzyme-induced activation of local angiotensin signaling is required for ascending aortic aneurysms in fibulin-4-deficient mice.Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention.Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition.Perindopril: beyond lowering blood pressure.Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene delivery.
P2860
Q21284671-CD1922FD-744D-40E0-885C-0EFDEAD5F4E1Q24297376-59F38816-1191-4FF8-8A99-00726B873777Q25257437-777EA13E-DD7A-4A37-8CA7-95111D553141Q27023126-400FC21E-29F5-4F6E-8477-5D197F2F3EA4Q33390497-C9820BBB-D418-4E01-9218-0AF87ED11437Q33504342-0269C2D3-AAC5-405D-8CCB-F82AE810DE80Q33755987-2944331E-46AD-45E5-8F32-115A3B223C8CQ33930863-361DD63F-14E1-44DB-8608-B87848AF97E1Q34003703-04CED3AB-15E8-4B57-808E-2F80310D38E2Q34117883-D6BAA4AA-FC68-4642-88D2-2B0AD52C2918Q34450527-B00D82B6-C563-478A-83CB-8659B38E702FQ34652136-DDC64349-3B6C-4AC0-B975-850F6FE95BF8Q34979673-A88C962C-586D-4533-9EF9-D0BE5ACF8DACQ35073288-A1FE5123-DB25-4BFE-9DE8-1A31F4E9D10CQ35137560-E41C2F9D-C13C-426E-9B99-ACC7FE00356BQ35137588-FCCF9197-76C0-4C7C-A58C-7EE7C0C24136Q35883274-BFEC37B3-C311-4F1F-9F07-5DB718DB55DDQ35974821-EA3A3588-89D7-4D3A-990A-78325F8D9579Q36066002-04CF7C30-3EC2-48E4-8880-9281BC5482B1Q36144638-23F71DA6-01DC-4AF3-82F4-DE607E2332F1Q36191584-0DF57594-967F-4F03-A6A2-92F145361E24Q36381958-D4FF8F73-2807-4E54-B3E1-2CFEA3A28E49Q36595721-8A4B3361-F13A-49BD-B3E9-009B51A558A8Q36642656-9E42EFD0-29AD-431E-952B-2989E9B62CE1Q36755237-38A9A4D3-901B-4C30-8C9F-DC011BBE1605Q36755471-8E8C4E47-5AE8-4C11-B145-EDC855B68CDAQ36814991-593EC47E-3F9C-4EE1-B561-28740BE8EF0EQ37043556-CAD58739-82ED-403D-BC74-2AF86DAF29D0Q37201619-8B68F864-E604-4071-BCE2-C1F114369117Q37265803-BF74FF8C-D5A6-44F4-83B3-9864CF6C6D34Q37298439-97CFA19D-1825-4B28-8331-23FCBF7AAEADQ37306295-17AF5391-D438-4E66-9041-CC2EBCF36AB4Q37402767-1FAE9A06-A0D0-4950-AF0B-8A4C7346FDFDQ37798001-E37E85B7-A62E-47D6-921E-76347A7BC51DQ38007893-C45E63AD-1431-40A4-88ED-0A3735A58EC0Q39620719-43853877-A11A-4F53-9D0C-5A05C0F95872Q39893116-F953C072-6FDE-4D3A-A306-38901088D088Q40097875-3D2D6C33-8270-4F01-A39D-E2C9BDE7EB7EQ40134736-A93E2EC8-8E6E-4393-B099-7C1E39A29751Q40322222-66C31656-8592-4C58-BACB-E48C93656E58
P2860
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The relevance of tissue angiot ...... mechanistic and endpoint data.
@ast
The relevance of tissue angiot ...... mechanistic and endpoint data.
@en
type
label
The relevance of tissue angiot ...... mechanistic and endpoint data.
@ast
The relevance of tissue angiot ...... mechanistic and endpoint data.
@en
prefLabel
The relevance of tissue angiot ...... mechanistic and endpoint data.
@ast
The relevance of tissue angiot ...... mechanistic and endpoint data.
@en
P2093
P50
P1476
The relevance of tissue angiot ...... mechanistic and endpoint data.
@en
P2093
C Johnston
D Celermajer
P304
P356
10.1016/S0002-9149(01)01878-1
P407
P577
2001-11-01T00:00:00Z